EA200701936A1 - Применение соляной кислоты для изготовления лекарственного средства для лечения повышенного давления - Google Patents
Применение соляной кислоты для изготовления лекарственного средства для лечения повышенного давленияInfo
- Publication number
- EA200701936A1 EA200701936A1 EA200701936A EA200701936A EA200701936A1 EA 200701936 A1 EA200701936 A1 EA 200701936A1 EA 200701936 A EA200701936 A EA 200701936A EA 200701936 A EA200701936 A EA 200701936A EA 200701936 A1 EA200701936 A1 EA 200701936A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- manufacture
- medicine
- application
- high pressure
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Настоящее изобретение относится к применению соляной кислоты (HCl) для изготовления лекарственных средств для лечения повышенного давления (гипертонии), а также конкрементов, где лекарственное средство представляет собой водный раствор, содержащий HCl, при этом указанный раствор имеет рН в диапазоне от 3 до 6,7. Лекарственное средство, полученное по настоящему изобретению, применяют для безопасного лечения гипертонии, оно обладает доказанным эффектом, может быть использовано для профилактики артериосклероза у гипертоников, а также может превращать соли кальция, которые вредны для организма, в кальций, который необходим организму.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005100493298A CN1830454A (zh) | 2005-03-10 | 2005-03-10 | 盐酸在制备治疗高血压药物中的应用 |
| PCT/CN2006/000329 WO2006094451A1 (fr) | 2005-03-10 | 2006-03-06 | Utilisation d’acide chlorhydrique pour la fabrication d’un medicament pour le traitement de l'hypertension |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200701936A1 true EA200701936A1 (ru) | 2008-02-28 |
| EA012616B1 EA012616B1 (ru) | 2009-10-30 |
Family
ID=36952948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200701936A EA012616B1 (ru) | 2005-03-10 | 2006-03-06 | Применение соляной кислоты для изготовления лекарственного средства для лечения повышенного давления |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20080317871A1 (ru) |
| EP (1) | EP1864671A4 (ru) |
| JP (1) | JP2008532952A (ru) |
| KR (1) | KR20070116087A (ru) |
| CN (1) | CN1830454A (ru) |
| AU (1) | AU2006222417A1 (ru) |
| BR (1) | BRPI0608022A2 (ru) |
| EA (1) | EA012616B1 (ru) |
| MX (1) | MX2007010918A (ru) |
| WO (1) | WO2006094451A1 (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101234123A (zh) * | 2008-02-02 | 2008-08-06 | 王德寿 | 一定浓度的盐酸水在治疗血管疾病中的应用 |
| WO2010009589A1 (zh) * | 2008-07-21 | 2010-01-28 | Liu Zhiren | 盐酸在制备治疗胃炎、肠炎和脉管炎药物中的应用 |
| CN105902565A (zh) * | 2016-05-11 | 2016-08-31 | 吴健忠 | 一种逆转动脉及其他软组织硬化的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6300362B1 (en) * | 1990-07-25 | 2001-10-09 | Novartis Ag (Formerly Sandoz Ltd.) | Stabilized pharmaceutical compositions comprising acid donors |
| US20040115134A1 (en) * | 1999-06-22 | 2004-06-17 | Elan Pharma International Ltd. | Novel nifedipine compositions |
| CN1301545A (zh) * | 1999-12-27 | 2001-07-04 | 王德山 | 一种复方降血压药 |
| JP2002255801A (ja) * | 2000-12-26 | 2002-09-11 | Mitsukan Group Honsha:Kk | 高血圧予防用組成物 |
| EP1379231A2 (en) * | 2001-04-06 | 2004-01-14 | Cytorex Biosciences, Inc. | Pharmacologically active strong acid solutions |
| US6866651B2 (en) * | 2002-03-20 | 2005-03-15 | Corazon Technologies, Inc. | Methods and devices for the in situ dissolution of renal calculi |
| EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
-
2005
- 2005-03-10 CN CNA2005100493298A patent/CN1830454A/zh active Pending
-
2006
- 2006-03-06 MX MX2007010918A patent/MX2007010918A/es not_active Application Discontinuation
- 2006-03-06 BR BRPI0608022-7A patent/BRPI0608022A2/pt not_active Application Discontinuation
- 2006-03-06 AU AU2006222417A patent/AU2006222417A1/en not_active Abandoned
- 2006-03-06 EP EP06705725A patent/EP1864671A4/en not_active Withdrawn
- 2006-03-06 JP JP2008500030A patent/JP2008532952A/ja active Pending
- 2006-03-06 WO PCT/CN2006/000329 patent/WO2006094451A1/zh active Application Filing
- 2006-03-06 US US11/908,053 patent/US20080317871A1/en not_active Abandoned
- 2006-03-06 KR KR1020077023137A patent/KR20070116087A/ko not_active Application Discontinuation
- 2006-03-06 EA EA200701936A patent/EA012616B1/ru not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1864671A1 (en) | 2007-12-12 |
| MX2007010918A (es) | 2008-03-13 |
| AU2006222417A1 (en) | 2006-09-14 |
| KR20070116087A (ko) | 2007-12-06 |
| EA012616B1 (ru) | 2009-10-30 |
| JP2008532952A (ja) | 2008-08-21 |
| EP1864671A4 (en) | 2010-01-20 |
| US20080317871A1 (en) | 2008-12-25 |
| CN1830454A (zh) | 2006-09-13 |
| WO2006094451A1 (fr) | 2006-09-14 |
| BRPI0608022A2 (pt) | 2009-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
| EA200900343A1 (ru) | Устойчивые оральные фармацевтические дозированные формы, содержащие опиоидный анальгетик | |
| ATE469674T1 (de) | 5-aminolävulinsäure-derivate zur behandlung von akne | |
| EA200800880A1 (ru) | Комбинация росиглитазона и донепезила, предназначенная для улучшения когнитивной функции | |
| ME01458B (me) | Kruta dozna forma koja sadrži inhibitor protonske pumpe i njena suspenzija | |
| CY1115961T1 (el) | Ανυδρη μορφη κρυσταλλικης μηλεϊνικης ορβεπιταντης (orvepitant maleate) | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| EA200701936A1 (ru) | Применение соляной кислоты для изготовления лекарственного средства для лечения повышенного давления | |
| UA94042C2 (ru) | Применение агомелатина в получении лекарственных средств, предназначенных для лечения синдрома смита-магениса | |
| CY1109393T1 (el) | Η χρηση κιγχονης για την παρασκευη ενος φαρμακου που διεγειρει την αγγειογενεση | |
| WO2008009655A3 (de) | Medizinische verwendung von n-phenylpropenoyl-aminosäurederivaten und verwandten verbindungen | |
| RU2006109966A (ru) | Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных | |
| CY1106129T1 (el) | Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος | |
| ATE295845T1 (de) | Prucaloprid-n-oxid | |
| EA201000739A1 (ru) | Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата | |
| TW200741011A (en) | Method for the diagnosis and treatment of cardiovascular diseases | |
| DE60327249D1 (de) | Anthranilsäureamide und ihre pharmazeutische verwendung | |
| DE60222662D1 (de) | Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung | |
| DE502006004735D1 (de) | Mittel zur behandlung von infektionen | |
| DE602006002126D1 (de) | Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa | |
| EA200701920A1 (ru) | Использование фенилацетильных производных для производства лекарственных средств для лечения болезни фон хиппеля-линдау (vhl) | |
| NO20054096L (no) | Inhibitor for perioperativ blodsukkerforhoyelse | |
| ATE442848T1 (de) | Isoxazolsäure-derivat zur linderung neuropathischer schmerzen | |
| IL162857A (en) | Use of an antigentically active substance and a gastric acid reducing substance for producing a vaccine for tumoral diseases | |
| DK1838392T3 (da) | Selenholdige medikamenter mod endotheliale vaskulære sygdomme |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |